美国军事卫生系统2014-2018年乙肝疫苗出生剂次接种模式分析
该研究基于美国国防部军事卫生系统2014-2018年活产婴儿的行政索赔数据,回顾性分析乙肝疫苗出生剂次接种趋势及拒绝接种相关因素。结果显示出生剂次接种覆盖率从79.6%升至88.1%,同时拒绝率从3.7%升至4.5%;未接种出生剂次与出生年份较早、白人母亲、母亲年龄较大、出生次序较高及住院时间较长相关。
要点
- 乙肝疫苗出生剂次覆盖率从2014年79.6%升至2018年88.1%。
- 疫苗拒绝率从2014年3.7%升至2018年4.5%。
- 未接种出生剂次与出生年份较早、白人母亲、母亲年龄较大、出生次序较高及住院时间较长相关。
核心结论
- 军事卫生系统乙肝疫苗出生剂次接种覆盖率较高且随时间增加,但拒绝率也同时上升。
主要发现
- 乙肝疫苗出生剂次接种覆盖率从2014年79.6%升至2018年88.1%(p < .0001)。
- 疫苗拒绝率从2014年3.7%升至2018年4.5%(p < .0001)。
- 疫苗拒绝或接种诊断代码缺失比例从2014年16.7%降至2018年7.4%。
- 未接种出生剂次的相关因素包括出生年份较早、白人母亲、母亲年龄较大、出生次序较高及住院时间较长。
临床怎么用
- 可利用行政索赔数据中的父母拒绝代码区分未接种原因,识别拒绝风险较高的家庭。
局限性
- 基于行政索赔数据,可能存在编码缺失或错误分类。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Since 2005, the universal hepatitis B (HepB) birth dose has been recommended for all medically stable infants weighing ≥2,000 g at birth. The timing of the birth dose provides a critical safeguard and prevents infection among infants born to HBsAg-positive mothers not identified prenatally. We assess infant HepB vaccination in the U.S. Department of Defense's Military Health System (MHS) to identify trends in vaccination coverage and sociodemographic factors associated with non-receipt of the birth dose, receiving the first HepB vaccine >3 days of life, and not receiving any HepB vaccine in the first 18 months of life utilizing parental refusal codes. To our knowledge, this is one of the first studies assessing trends in parental refusal of the HepB birth dose utilizing administrative claims parental refusal codes. METHODS: We conducted a retrospective cohort analysis of MHS live births from January 1, 2014 through December 31, 2018 utilizing administrative claims data. Data were included from 44 hospitals in 24 unique states, territories, or countries. We analyzed diagnosis codes for vaccine refusal and vaccination and current procedural terminology (CPT) codes to identify vaccination patterns. Generalized linear mixed effects models with a logit link were used to assess factors associated with vaccination patterns. RESULTS: HepB birth dose vaccination coverage increased from 79.6% in 2014 to 88.1% in 2018 (p < .0001). Refusal rates also increased from 3.7% in 2014 to 4.5% in 2018 (p < .0001). The percentage of patients with missing diagnosis codes for vaccine refusal or vaccination decreased from 16.7% in 2014 to 7.4% in 2018. Factors associated with non-receipt of the birth dose included earlier year of birth, white maternal race, higher maternal age, higher birth order, and longer infant length of stay in hospital. CONCLUSION: Vaccination coverage for HepB birth dose is high in the MHS and increased over time; concurrently, refusal rates also increased over time. Utilizing administrative claims data has the benefit of differentiating reasons for non-receipt of the birth dose over time.
引用
- Deerin JF, Clifton R, Elmi A, et al. Hepatitis B birth dose vaccination patterns in the military health System, 2014-2018. Vaccine. 2021. PMID: 33741189. doi:10.1016/j.vaccine.2021.03.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。